Elisabeth Von Guggenberg

Dr. Elisabeth Von Guggenberg

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
MGMichael Gabriel
Michael Gabriel
Clemens DecristoforoClemens Decristoforo
Clemens Decristoforo
DKDorota Kendler
Dorota Kendler
GDGeorg Dobrozemsky
Georg Dobrozemsky
DHDirk Heute
Dirk Heute
IVIrene J. Virgolini
Irene J. Virgolini
The aim of this study was to evaluate the diagnostic value of a new somatostatin analog, 68Ga-labeled 1,4,7,10-tetraazacyclododecane-N,N′,N″,N″′-tetraacetic acid-d-Phe1-Tyr3-octreotide (68Ga-DOTA-TOC), for PET in patients with known or suspected neuroendocrine tumors. PET was compared with conventional scintigraphy and dedicated CT. Methods: Eighty-four patients (48 men, 36 women; age range, 28–79 y; mean age ± SD, 58.2 ± 12.2 y) were prospectively studied. For analysis, patients were divided into 3 groups: detection of unknown primary tumor in the presence of clinical or biochemical suspicion of neuroendocrine malignancy (n = 13 patients), initial tumor staging (n = 36 patients), and follow-up after therapy (n = 35 patients). Each patient received 100–150 MBq 68Ga-DOTA-TOC. Imaging results of PET were compared with 99mTc-labeled hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) and 111In-DOTA-TOC. CT was also performed on every patient using a multidetector scanner. Each imaging modality was interpreted separately by observers who were unaware of imaging findings before comparison with PET. The gold standard for defining true-positive (TP), true-negative (TN), false-positive (FP), and false-negative (FN) results was based on all available histologic, imaging, and follow-up findings. Results: PET was TP in 69 patients, TN in 12 patients, FP in 1 patient, and FN in 2 patients, indicating a sensitivity of 97%, a specificity of 92%, and an accuracy of 96%. The FP finding was caused by enhanced tracer accumulation in the pancreatic head, and the FN results were obtained in patients with a tumor of the gastrointestinal tract displaying liver metastases. 68Ga-DOTA-TOC showed higher diagnostic efficacy compared with SPECT (TP in 37 patients, TN in 12 patients, FP in 1 patient, and FN in 34 patients) and diagnostic CT (TP in 41 patients, TN in 12 patients, FP in 5 patients, and FN in 26 patients). This difference was of statistical significance (P < 0.001). However, the combined use of PET and CT showed the highest overall accuracy. Conclusion: 68Ga-DOTA-TOC PET shows a significantly higher detection rate compared with conventional somatostatin receptor scintigraphy and diagnostic CT with clinical impact in a considerable number of patients.

31 January 2017 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
CUChristian Uprimny
Christian Uprimny
AKAlexander Stephan Kroiss
Alexander Stephan Kroiss
Clemens DecristoforoClemens Decristoforo
Clemens Decristoforo
JFJosef Fritz
Josef Fritz
EGElisabeth Von Guggenberg
Elisabeth Von Guggenberg
IVIrene Johanna Virgolini
Irene Johanna Virgolini

13 April 2011 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
PKPeter A. Knetsch
Peter A. Knetsch
MPMilos Petrik
Milos Petrik
CGChristoph M. Griessinger
Christoph M. Griessinger
CRChristine Rangger
Christine Rangger
Melpomeni FaniMelpomeni Fani
Melpomeni Fani
RHRoland Haubner
Roland Haubner

28 October 2008 in Proteomics
Verified
Journal Article
Closed access
PDF file
Ira-Ida SkvortsovaIra-Ida Skvortsova
Ira-Ida Skvortsova
SSSergej Skvortsov
Sergej Skvortsov
TSTaras Stasyk
Taras Stasyk
URUma Raju
Uma Raju
BPBela‐Andre Popper
Bela‐Andre Popper
PLPeter Lukas
Peter Lukas

1 November 2006 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
Clemens DecristoforoClemens Decristoforo
Clemens Decristoforo
BFBluma Faintuch-Linkowski
Bluma Faintuch-Linkowski
ARAna Rey
Ana Rey
EGElisabeth Von Guggenberg
Elisabeth Von Guggenberg
MRMarco Rupprich
Marco Rupprich
RHRoland Haubner
Roland Haubner

1 November 2007 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
Clemens DecristoforoClemens Decristoforo
Clemens Decristoforo
RKRoger Knopp
Roger Knopp
EGElisabeth Von Guggenberg
Elisabeth Von Guggenberg
MRMarco Rupprich
Marco Rupprich
TDThorsten Dreger
Thorsten Dreger
RHRoland Haubner
Roland Haubner
Generator-produced Ga has attracted increasing interest for radiolabelling peptides used in PET applications. So far, the synthesis of Ga-peptide radiopharmaceuticals is mainly based on semi-automated systems. Here we describe a fully automated approach for the synthesis of Ga-labelled peptides. A commercially available Ga generator was eluted with 0.1 mol . l HCl. Reaction parameters such as buffer conditions, pH range, reaction temperature and time, volume of reaction solution and generator fraction were optimized for labelling DOTA-Tyr-octreotide (DOTATOC). Reaction yields, pH, radiochemical purity, sterility, endotoxins, breakthrough of Ge and final Ge content were determined. A fully automated radiopharmaceutical synthesis device based on a modular concept for remote-controlled processing was developed and evaluated for a number of DOTA-derivatized peptides. DOTATOC could be labelled in almost quantitative yields by heating 10-50 nmol peptide at pH 3.5-4.0 for 5 min at 95 degrees C in 1.5 ml. Purification using a reversed-phase cartridge was required to avoid any potential Ge breakthrough: final activities of Ge were below 100 Bq . ml. Automated synthesis resulted in overall decay-corrected reaction yields of about 60% within 10 min. Even after 1 year using a 1110 MBq generator more than 130 MBq Ga-DOTATOC could be obtained. Moreover, it was demonstrated that a variety of DOTA-derivatized peptides can be labelled using identical reaction conditions with high yields. The system described allows the fully automated, efficient and rapid preparation of Ga-DOTA-derivatized peptides. It has been used successfully and reliably for routine preparations in clinical studies.